| | 79517-01-4 Basic information More.. |
| Product Name: | Octreotide | | Synonyms: | SMS-201-995;[r-(r*,r*)]-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide;OCTREOTIDE;OCTREOTIDE (SMS 201-995), ACETATE;cyclic(2-7)-disulfide,(r-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl);Octreotide
(D-Phe5,Cys6·11,D-Trp8,L-Threoninol12)-SoMatostatin-14 (5-12), SMS-201-995;D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxyMethyl)propyl]-;D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7) | | CAS: | 79517-01-4 | | MF: | C51H70N10O12S2 | | MW: | 1079.3 | | EINECS: | 616-695-4 | | Mol File: | 79517-01-4.mol |  |
Use
Octreotide is clinically used for the treatment of esophageal varices caused by portal hypertension, acromegaly, gastrointestinal bleeding including cirrhosis, esophageal varices bleeding, peptic ulcer bleeding and stress ulcer bleeding, pancreatic diseases including heavy acute pancreatitis, pancreatic trauma, or pancreatic fistula after surgery, and prevention of complications after pancreas surgery. It is also used for gastrointestinal fistula, digestive endocrine tumors such as vasoactive intestinal peptide tumors, gastrinoma, glucagon tumors, ectopic acth syndrome, carcinoid syndrome, and it is used for acromegaly, exophthalmus hyperthyroidism disease, after the removal of the entire colon appearing persistent and intractable diarrhea, aids-related diarrhea. Intrathecal injection of this product can treat cancer pain.
- Octreotide
-
- US $1.00 / g
- 2024-04-16
- CAS:79517-01-4
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 100kg
- Octreotide acetate salt
-
- US $1.00-1.00 / mg
- 2024-04-15
- CAS:79517-01-4
- Min. Order: 1mg
- Purity: 99%
- Supply Ability: 20mg/week
- Octreotide
-
- US $0.00-0.00 / Box
- 2024-04-12
- CAS:79517-01-4
- Min. Order: 1Box
- Purity: 99
- Supply Ability: 50000KG/month
|
|
79517-01-4
Recommend Suppliers |
|